Barclays
PROK icon

Barclays’s ProKidney PROK Stock Holding History

Barclays’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$142K Buy
85,332
+69,211
+429% +$117K ﹤0.01% 4165
2026
Q2 		$32.9K Sell
16,121
-130,163
-89% -$238K ﹤0.01% 4459
2026
Q1 		$262K Sell
146,284
-23,717
-14% -$50.3K ﹤0.01% 3539
2025
Q4 		$381K Buy
170,001
+170,000
+17,000,000% +$447K ﹤0.01% 4007
2025
Q3 		$2 Hold
1
– – ﹤0.01% 5438
2025
Q2 		$1 Sell
1
-119,038
-100% -$92.7K ﹤0.01% 5200
2025
Q1 		$104K Sell
119,039
-52,758
-31% -$73.2K ﹤0.01% 4392
2024
Q4 		$290K Buy
171,797
+25,476
+17% +$45.9K ﹤0.01% 4135
2024
Q3 		$281K Buy
146,321
+124,667
+576% +$283K ﹤0.01% 4127
2024
Q2 		$53.3K Sell
21,654
-9,943
-31% -$26.7K ﹤0.01% 4184
2024
Q1 		$51.8K Sell
31,597
-30,218
-49% -$44.4K ﹤0.01% 4608
2023
Q4 		$110K Buy
61,815
+48,234
+355% +$103K ﹤0.01% 4619
2023
Q3 		$62.2K Sell
13,581
-4,260
-24% -$40.8K ﹤0.01% 3778
2023
Q2 		$200K Buy
+17,841
New +$190K ﹤0.01% 3239

Other funds holding PROK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Brown University
Brown University Providence, Rhode Island $147M AUM 5.01% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Barclays's PROK Position: Q3 2026 in Review

Barclays increased its ProKidney (PROK) stake by 429% in Q3 2026, buying an estimated $117K and bringing the position to 85,332 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #4165.

Barclays first reported a position in PROK in Q2 2023 and has held it in 14 quarters since. The position peaked at $381K in Q4 2025. 32 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Barclays held 85,332 shares of ProKidney worth $142K as of Q3 2026.
  • Barclays bought 69,211 ProKidney shares in Q3 2026, an estimated $117K.
  • ProKidney made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4165 holding.
  • Barclays first reported a position in ProKidney in Q2 2023 and has held it in 14 quarters since.
  • Barclays's ProKidney position peaked at $381K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.